Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

MJ-9067

Known as: MJ 9067, MJ9067 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryEncainide is a new anti-arrhythmic drug, which is highly effective against ventricular extrasystoles, both single and… Expand
  • table 1
  • table 2
1984
1984
The electrophysiological effects of encainide (MJ9067) on canine subendocardial Purkinje fibers surviving infarction were… Expand
1982
1982
Encainide (MJ 9067) was given intravenously at 1, 2, or 5 mg/kg and orally at 1, 2.5, 5, or 10 mg/kg to conscious dogs 18--23 h… Expand
1980
1980
The right ventricular epicardial ventricular fibrillation threshold (VFT) was determined during paced supraventricular rhythm… Expand
1977
1977
A novel benzanilide derivative, MJ 9067, has been shown to abolish experimental atrial and ventricular arrhythmiase effectively… Expand